Andrew J Woo
Overview
Explore the profile of Andrew J Woo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
890
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McGrath F, Francis A, Fatovich D, Macdonald S, Arendts G, Woo A, et al.
Clin Transl Immunology
. 2022 Dec;
11(12):e1435.
PMID: 36583159
Objective: Mechanisms underlying the anaphylactic reaction in humans are not fully understood. Here, we aimed at improving our understanding of anaphylaxis by investigating gene expression changes. Methods: Microarray data set...
2.
Kim M, Singh M, Lee B, Hibbs M, Richardson K, Ellies L, et al.
Oncogenesis
. 2022 Oct;
11(1):60.
PMID: 36207293
The MYC proto-oncogene (MYC) is one of the most frequently overexpressed genes in breast cancer that drives cancer stem cell-like traits, resulting in aggressive disease progression and poor prognosis. In...
3.
Beveridge D, Richardson K, Epis M, Brown R, Stuart L, Woo A, et al.
Sci Rep
. 2021 Sep;
11(1):18003.
PMID: 34504167
RNA-based therapeutics are emerging as innovative options for cancer treatment, with microRNAs being attractive targets for therapy development. We previously implicated microRNA-642a-5p (miR-642a-5p) as a tumor suppressor in prostate cancer...
4.
Golden E, Rashwan R, Woodward E, Sgro A, Wang E, Sorolla A, et al.
Nat Commun
. 2021 Mar;
12(1):1920.
PMID: 33772001
Adipogenesis associated Mth938 domain containing (AAMDC) represents an uncharacterized oncogene amplified in aggressive estrogen receptor-positive breast cancers. We uncover that AAMDC regulates the expression of several metabolic enzymes involved in...
5.
Salik B, Yi H, Hassan N, Santiappillai N, Vick B, Connerty P, et al.
Cancer Cell
. 2020 Jun;
38(2):263-278.e6.
PMID: 32559496
Signals driving aberrant self-renewal in the heterogeneous leukemia stem cell (LSC) pool determine aggressiveness of acute myeloid leukemia (AML). We report that a positive modulator of canonical WNT signaling pathway,...
6.
Woo A, Patry C, Ghamari A, Pregernig G, Yuan D, Zheng K, et al.
Blood Adv
. 2019 Aug;
3(16):2499-2511.
PMID: 31455666
Erythroid maturation requires the concerted action of a core set of transcription factors. We previously identified the Krüppel-type zinc finger transcription factor Zfp148 (also called ZBP-89) as an interacting partner...
7.
Gonzales-Aloy E, Connerty P, Salik B, Liu B, Woo A, Haber M, et al.
Haematologica
. 2019 Feb;
104(7):e296-e299.
PMID: 30792205
No abstract available.
8.
Lynch J, Salik B, Connerty P, Vick B, Leung H, Pijning A, et al.
Leukemia
. 2019 Jan;
33(6):1400-1410.
PMID: 30622285
Abnormal metabolism is a fundamental hallmark of cancer and represents a therapeutic opportunity, yet its regulation by oncogenes remains poorly understood. Here, we uncover that JMJD1C, a jumonji C (JmjC)-containing...
9.
Wang E, Sorolla A, Cunningham P, Bogdawa H, Beck S, Golden E, et al.
Oncogene
. 2018 Aug;
38(1):140-150.
PMID: 30076412
Overexpression of MYC oncogene is highly prevalent in many malignancies such as aggressive triple-negative breast cancers (TNBCs) and it is associated with very poor outcome. Despite decades of research, attempts...
10.
Beck S, Lee B, Rhee C, Song J, Woo A, Kim J
Nat Commun
. 2014 Nov;
5:5490.
PMID: 25405324
Both transcriptional and epigenetic regulations are fundamental for the control of eukaryotic gene expression. Here we perform a compendium analysis of >200 large sequencing data sets to elucidate the regulatory...